Malik Fady Ibraham
EVP Research & Development
Malik Fady Ibraham has filed 27 SEC Form 4 filings (53 transaction rows) across 2 companies, including CYTK, RCKT, with disclosures dating back to 2025. 23 of those filings fall inside the rolling window. Most recent filing: Oct 20, 2026.
On the most recent filing, Malik Fady Ibraham is listed as EVP Research & Development at CYTOKINETICS INC. Inside the rolling window, Malik Fady Ibraham reported no open-market purchases and 19 open-market sales totaling $4.8M in CYTK. The largest disclosed transaction in the window is a sale of 12,033 CYTK shares on Mar 17, 2026, worth $748K.
Companies traded
Other insiders at CYTK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.8M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CYTK | EVP Research & Development | Sale | 3,500 | $224K | Oct 20 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $215K | Oct 6 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $239K | Sep 22 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $264K | Sep 8 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $265K | Aug 18 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $282K | Jul 23 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $303K | Jul 7 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $278K | Jun 23 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $238K | Jun 9 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $265K | May 20 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $271K | May 5 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 3,500 | $230K | Apr 21 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 4,500 | $293K | Apr 8 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 12,033 | $748K | Mar 18 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 2,907 | $177K | Mar 10 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 2,200 | $135K | Dec 16 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 2,200 | $141K | Dec 2 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 2,200 | $146K | Nov 18 | SEC ↗ | |
| CYTK | EVP Research & Development | Sale | 2,295 | $137K | Nov 4 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 21, 2025 | CYTK | Sale | $123K |
| Oct 7, 2025 | CYTK | Sale | $121K |
| Sep 23, 2025 | CYTK | Sale | $99K |
| Sep 9, 2025 | CYTK | Sale | $103K |
Frequently asked questions
How many SEC Form 4 filings has Malik Fady Ibraham made?
Malik Fady Ibraham has filed 27 SEC Form 4 filings (53 transaction rows) across 2 companies, including CYTK, RCKT since 2025.
Which companies does Malik Fady Ibraham trade?
Malik Fady Ibraham has filed SEC Form 4 disclosures for 2 companies, including CYTK, RCKT.
When was Malik Fady Ibraham's most recent SEC Form 4 filing?
Malik Fady Ibraham's most recent SEC Form 4 filing on Tracefour is dated Oct 20, 2026.
What is Malik Fady Ibraham's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Malik Fady Ibraham is listed as EVP Research & Development.
What is Malik Fady Ibraham's total buy and sell value in the current window?
Inside the rolling retention window, Malik Fady Ibraham bought $0 and sold $4.8M based on SEC Form 4 filings.
What was Malik Fady Ibraham's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,033 CYTK shares on 2026-03-17, worth $748K, per SEC Form 4 filings.